Invivyd, Inc.
Invivyd, Inc. (IVVD) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IVVD · as of Sep 30, 2025
Ownership Breakdown
82
Institutional Holders
▲ 15 vs Q2
$163.79M
Total Inst. Value
▲ $120.57M vs Q2
132.73M
Shares Outstanding
freeFloat 66.17%
148.79M
13F Shares Held
▲ 88.34M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IVVD largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
JANUS HENDERSON GROUP PLC biological products, (no diagnostic substances) | 25.38M | 14.92% | 14.92% | $28.05B | Nov 14, 2025 | NEW |
POINT72 ASSET MANAGEMENT, L.P. biological products, (no diagnostic substances) | 20.30M | 11.93% | 11.93% | $22.33B | Nov 14, 2025 | NEW |
MAVERICK CAPITAL LTD biological products, (no diagnostic substances) | 18.97M | 11.15% | 11.15% | $20.87B | Nov 14, 2025 | ▲ 8.74M |
RA CAPITAL MANAGEMENT, L.P. biological products, (no diagnostic substances) | 17.12M | 10.06% | 10.06% | $18.83B | Nov 14, 2025 | NEW |
MITHRIL II GP LP biological products, (no diagnostic substances) | 11.24M | 6.61% | 6.61% | $12.37B | Nov 12, 2025 | — held |
DRIEHAUS CAPITAL MANAGEMENT LLC biological products, (no diagnostic substances) | 10.11M | 5.94% | 5.94% | $11.12B | Nov 14, 2025 | NEW |
M28 CAPITAL MANAGEMENT LP biological products, (no diagnostic substances) | 9.25M | 5.43% | 5.43% | $10.17B | Nov 13, 2025 | — held |
ADAR1 CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 7.37M | 4.33% | 4.33% | $8.11B | Nov 14, 2025 | NEW |
683 CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 6.30M | 3.70% | 3.70% | $6.93B | Nov 14, 2025 | ▲ 3.23M |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 5.76M | 3.39% | 3.39% | $6.34B | Nov 7, 2025 | ▲ 1.83M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
20
Increased
+16.60M shares14
New Positions
first time holders8
Decreased
−3.00M shares0
Sold Out
fully exitedNet shares change (top 50)
+13.60M
+16.60M / −3.00M
Net new holders
+26
14 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IVVD insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
6
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Royan Ajay director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
MCLAUGHLIN KEVIN F director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
MCGUIRE TERRANCE director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
Elia Marc See Remarks | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
BOLNO PAUL director | May 19, 2026 | Award | 32,876 | $1.04 | $34.2K | 32.9K | Form 4 ↗ |
Berry Tamsin director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
Allen Robert D. III Chief Scientific Officer | Feb 17, 2026 | Sale | 18,189 | $1.54 | $28.0K | 133.9K | Form 4 ↗ |
Allen Robert D. III Chief Scientific Officer | Feb 18, 2026 | Sale | 19,392 | $1.58 | $30.6K | 114.5K | Form 4 ↗ |
Green Julie Chief Human Resources Officer | Feb 17, 2026 | Sale | 19,663 | $1.54 | $30.3K | 128.7K | Form 4 ↗ |
Green Julie Chief Human Resources Officer | Feb 18, 2026 | Sale | 20,964 | $1.58 | $33.1K | 107.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Invivyd, Inc. (IVVD) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 33.83%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Invivyd, Inc. is JANUS HENDERSON GROUP PLC, holding approximately 25.38 million shares — equal to 14.92% of outstanding shares — as of September 30, 2025.
A total of 82 institutional investors currently hold IVVD stock, with a combined institutional value of approximately $163,792,663 as of the most recent 13F filing period.
Frequently asked questions
IVVD ownershipInvivyd, Inc. (IVVD) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is JANUS HENDERSON GROUP PLC with a 14.92% stake. Company insiders hold 33.83%. Data sourced from SEC Form 13F as of September 30, 2025.